Results 161 to 170 of about 143,948 (293)

Elevated NPM1 and FBL expression correlates with prostate cancer aggressiveness and progression

The Journal of Pathology, Volume 267, Issue 1, Page 56-68, September 2025.
Abstract The nucleolus is a membrane‐less body present in the nucleus of the cell. The nucleolus is mainly involved in ribosomal RNA (rRNA) transcription and ribosome biogenesis for protein translation. During cancer formation, nucleolar morphology is altered, and many nucleolar proteins are expressed at a higher level, leading to enhanced ribosome ...
Sarina Saffarian, Ziwei Cai, Jordan Lam, Htoo Zarni Oo, Syam Somasekharan   +4 more
wiley   +1 more source

Comorbid Diabetes Mellitus Contributes to Residual Overactive Bladder After Transurethral Surgery for Benign Prostatic Hyperplasia. [PDF]

Int J Urol
ABSTRACT Objectives This study aimed to investigate the factors associated with residual overactive bladder after transurethral surgery for benign prostatic hyperplasia. Methods This study retrospectively analyzed male patients aged 50 years or older who underwent transurethral surgery for benign prostatic hyperplasia with overactive bladder between ...
Miki K, Kiba K, Maenosono D, Akashi Y, Hashimoto M, Yamamoto Y, Fujita K, Hirayama A.   +7 more
europepmc   +2 more sources

A Multimarker Model for Prostate Cancer Risk Assessment: Improving Diagnostic Accuracy Beyond PSA

The Prostate, Volume 85, Issue 12, Page 1096-1103, September 2025.
ABSTRACT Objective This study aimed to evaluate the association between biochemical markers and prostate cancer (PCa) risk by analyzing patients with benign prostatic hyperplasia (BPH) and PCa. Additionally, the study sought to assess the diagnostic accuracy of a multimarker model compared to prostate‐specific antigen (PSA) alone.
Penglu Yang, Bin Yang
wiley   +1 more source

Drug treatment for benign prostatic hyperplasia [PDF]

, 1997
Andrew Farmer, J. Noble
openalex   +1 more source

PRMT5:MEP50 Are Mediators of Treatment‐Induced Neuroendocrine Differentiation in Prostate Cancer

The Prostate, Volume 85, Issue 13, Page 1196-1207, September 15, 2025.
ABSTRACT Background Neuroendocrine prostate cancer (NEPC) is a lethal subtype of prostate cancer responsible for an estimated 20%–30% of castration‐resistant prostate cancer (CRPC) deaths. While NEPC can arise spontaneously, the majority of these cases emerge as treatment‐induced NEPC (tNEPC).
Hye Seung Nam, Andrew Michael Asberry, Xuehong Deng, Sheng Liu, Jiaoti Huang, Chang‐Deng Hu, Jun Wan, Michael K. Wendt   +7 more
wiley   +1 more source

Screening for prostatic cancer: the case for. [PDF]

, 1993
Allhoff, E. P., Kuczyk, M., Liedke, S. G., Stief, Christian Georg   +3 more
core   +1 more source

Retrospective analysis of management of patients presenting with acute urinary retention due to benign prostatic hyperplasia: A hospital based study

, 1970
RK Pandit, CS Agrawal, Pawan Raj Chalise, Ganga Sapkota   +3 more
openalex   +2 more sources

Magnetic resonance imaging‐guided transurethral ultrasound ablation for benign prostatic obstruction: 1‐year clinical outcomes of a phase II study

BJU International, Volume 136, Issue 3, Page 473-483, September 2025.
Objectives To evaluate the safety and efficacy of magnetic resonance imaging (MRI)‐guided transurethral ultrasound ablation (TULSA) as a minimally invasive alternative for benign prostatic obstruction (BPO). Patients and Methods This prospective, single‐centre, early phase II study (NCT03350529) included 30 men with BPO scheduled for primary ...
Antti Viitala, Mikael Anttinen, Pietari Mäkelä, Heikki Pärssinen, Pertti Nurminen, Teija Sainio, Jani Saunavaara, Pekka Taimen, Roberto Blanco Sequeiros, Peter J. Boström   +9 more
wiley   +1 more source

Diagnosis and Treatment of Benign Prostatic Hyperplasia: Practice Patterns of Primary Care Physicians [PDF]

, 1997
Mary Collins, Michael J. Barry, Bin Lin, Richard G. Roberts, Joseph E. Oesterling, Floyd J. Fowler   +5 more
openalex   +1 more source

Lymphocyte Transformation Tests and Patch Tests to Identify Drugs Potentially Associated With Bullous Pemphigoid Development

International Journal of Dermatology, Volume 64, Issue 9, Page 1636-1643, September 2025.
ABSTRACT Background Bullous pemphigoid (BP) is the most common autoimmune blistering disease, with a rising incidence in the elderly. BP is associated with multiple triggering factors, including drug exposure. However, evidence in this respect is limited, and the underlying immune mechanisms remain unknown.
Belen de Nicolas‐Ruanes, Carlos Fernandez‐Lozano, Patricia Gutierrez‐Canales, Asuncion Ballester‐Martinez, Natalia Rodriguez‐Otero, Javier Martinez‐Botas, Belén de la Hoz Caballer, Ana Andres‐Martin, Emilio Solano‐Solares, Maria Esther Gomez‐Salazar Lopez‐Silanes, Laura Gisella Diaz‐Montalvo, Diana M. Arrebola, Vivian Lizeth Stewart‐Delcid, Emilio Garcia‐Mouronte, Carlos Azcarraga‐Llobet, Emilio Berna‐Rico, Sonia Ortega‐Sanchez, Montserrat Fernandez‐Guarino   +17 more
wiley   +1 more source